VC  RiverVest Venture Partners

http://www.rivervest.com





     Office Locations:

12730 High Bluff Drive, Suite 160
San Diego, CA 92130
Phone: 314-726-6700
Fax: 314-726-6715

Get all office locations for this firm with a National Database subscription or Southern California Database subscription.
 

Stages:

  • Early
  • Expansion
  • Seed


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded in September 2000, RiverVest Venture Partners has focused exclusively on innovations in life sciences. The firm identifies, found, and actively incubate promising life sciences companies, particularly in the medical device and biopharmaceutical industries. RiverVest provides practical advice and strategic leadership to help entrepreneurs drive early-stage companies forward. RiverVest also invests in select later-stage life science companies to diversify risk and maximize portfolio returns. Since its inception, RiverVest has raised two investment funds with $1 billion under management, and supported more than 53 investments.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or Southern California Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or Southern California Database subscription.
    Derek Rapp Managing Director
    Jay W. Schmelter Managing Director
    John McKearn PhD Managing Director
    Karen Spilizewski Vice President
    Marilyn J. Slavich Controller

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      03/19/2024


      Engrail Therapeutics


      CA


      $157,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: